Beruflich Dokumente
Kultur Dokumente
Review article
A R T I C L E I N F O A B S T R A C T
Article history: Introduction: Tourette syndrome (TS) is a tic disorder with multiple motor and vocal or phonic tics. The
Received 29 July 2016 effect of acupuncture for TS has not been well established.
Received in revised form 1 September 2016 Methods: English, Japanese, Korean and Chinese databases, were explored systematically for randomized
Accepted 2 September 2016
controlled trials investigating the use of acupuncture for treating TS, up to August 2016, without language
Available online xxx
restrictions. All studies evaluating the effects of acupuncture were identified. Studies assessing the effect
of moxibustion were excluded. All ages were considered. Data were extracted independently using
Keywords:
predefined data fields, including study quality indicators. All pooled analyses were based on random-
Acupuncture
Tic disorders
effects models. The authors individually evaluated risk of bias with the Cochrane Collaboration’s tools.
Tics Results: Nineteen Studies (N = 1483) were systematically reviewed. A significant benefit was observed for
Tourette syndrome studies comparing acupuncture versus medication (pooled the risk ratio showed improvement by 1.17;
Randomized controlled trials 95% confidence interval: 1.10–1.25, p < 0.00001). Reporting of adverse events was poor with only one
Systematic review study which reported that there were no adverse events in their acupuncture treatment group.
Conclusions: This analysis provided limited evidence from studies for the practice of acupuncture in
treating TS. However, the conclusions were limited by a high risk of bias. Future studies are needed to
verify the superior features of acupuncture. Further study into the efficacy and safety of acupuncture is
warranted.
ã 2016 Published by Elsevier GmbH.
Contents
1. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
2. Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
2.1. Information sources and search strategy . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
2.2. Eligibility criteria and study selection . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
2.2.1. Types of studies . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
2.2.2. Types of participants . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
2.2.3. Types of interventions . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
2.2.4. Types of outcome measures . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
2.3. Data collection . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
2.4. Assessment of risk of bias . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
2.5. Summary measures and synthesis of results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
3. Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
3.1. Study characteristics . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
3.2. Risk of bias in included studies . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
* Correspondence to: Hospital of Korean Medicine, Kyung Hee University Medical Center, Kyung Hee University, 23, Kyungheedae-ro, Dongdaemun-gu, Seoul, 02447,
Repubic of Korea.
E-mail address: chosh@khmc.or.kr (S.-H. Cho).
http://dx.doi.org/10.1016/j.eujim.2016.09.001
1876-3820/ã 2016 Published by Elsevier GmbH.
Please cite this article in press as: S.-Y. Chung, et al., Acupuncture for Tourette syndrome: A systematic review and meta-analysis, Eur. J. Integr.
Med. (2016), http://dx.doi.org/10.1016/j.eujim.2016.09.001
G Model
EUJIM 598 No. of Pages 8
2 S.-Y. Chung et al. / European Journal of Integrative Medicine xxx (2016) xxx–xxx
Please cite this article in press as: S.-Y. Chung, et al., Acupuncture for Tourette syndrome: A systematic review and meta-analysis, Eur. J. Integr.
Med. (2016), http://dx.doi.org/10.1016/j.eujim.2016.09.001
G Model
EUJIM 598 No. of Pages 8
S.-Y. Chung et al. / European Journal of Integrative Medicine xxx (2016) xxx–xxx 3
2.2.4. Types of outcome measures results’; and 3) ‘unclear risk of bias’, ‘plausible bias that raises some
The primary outcome measures were tic severity or response doubt about the results’. If the raters disagreed, the final rating was
rate, which included the number, intensity, complexity, and made by consensus.
interference. These outcomes were measured by the patients or
a clinician, using rating scales with Yale Global Tic Severity Rating 2.5. Summary measures and synthesis of results
Scale (YGTSS), the Tic Symptom Self Report, a video protocol, or a
self-rating scale such as the TS Symptom List. The secondary Study characteristics and quality ratings were assessed. A
outcomes analyzed were any rated adverse effects. random-effects model examined the risk ratio (RR) using Review
Manager (RevMan) (ver. 5.3. Copenhagen: The Nordic Cochrane
2.3. Data collection Centre, The Cochrane Collaboration, 2014).
Where possible we used a random-effects model using Mantel-
Data from the included studies in the review, data were Haenszel weights for synthesis of results because the true effect
individually recorded by each reviewer and entered into an Excel sizes (ESs) were expected to vary across trials due to different study
spreadsheet. Trials were coded by two raters for reliability, and characteristics. A random effects model calculated the RR and its
results were compared to confirm accuracy. Rater differences were 95% confidence interval (CI) for treatment response between trials.
settled through discussion and agreement. Trials were coded for We recognize that the random-effects model is generally a more
the following characteristics (sample size, percent of sample on tic plausible match. Heterogeneity of RR was assessed using the forest
medication, patients with TS, mean age of patients; number of plot, Q statistic, and I2 statistic. All groups with ‘more improved’ or
acupuncture sessions, mean difference(MD), treatment response, ‘improved’ of the improvement rating were classified as “treat-
inclusion of a comparison condition, and study methodology). ment responses” The number of responders and non-responders
was calculated and the RR for each trial. For continuous outcomes
2.4. Assessment of risk of bias we assessed a MD using RevMan. MDs were considered on the
random-effects model because of no statistically significant
The authors individually evaluated risk of bias in agreement heterogeneity. We also analyzed the standardized MD measures.
with the Cochrane Collaboration’s tools for evaluating quality and ESs were calculated using change means because doing so
risk of bias [23]. This tool considers ‘how the sequence was increases the precision of ES estimators by controlling for
generated, how allocation was concealed, the integrity of blinding, pretreatment group differences in tic severity. Publication bias
the completeness of outcome data, selective reporting and other was assessed by graphic assessment of the funnel plot. Subgroup
biases’. The risk of bias in each domain were evaluated and analysis was undertaken, of types of acupuncture intervention.
categorized into three groups: 1) ‘low risk of bias’, ‘plausible bias However, the final data assessed were from a meta-analysis. The
unlikely to seriously alter the results’; 2) ‘high risk of bias’, aim of the meta-analysis was to explore the effect of acupuncture
‘plausible risk of bias that seriously weakens confidence in the intervention for TS. Sensitivity analysis was not performed because
Please cite this article in press as: S.-Y. Chung, et al., Acupuncture for Tourette syndrome: A systematic review and meta-analysis, Eur. J. Integr.
Med. (2016), http://dx.doi.org/10.1016/j.eujim.2016.09.001
G Model
EUJIM 598 No. of Pages 8
4 S.-Y. Chung et al. / European Journal of Integrative Medicine xxx (2016) xxx–xxx
there were not enough studies in the evaluation that examined the of acupuncture in the treatment for TS in all ages were included.
change in robustness of the sensitivity. Seven studies were identified and excluded as acupuncture was
used in conjunction with another treatment option as an
3. Results intervention treatment. The remaining 19 studies [24–42] met
the inclusion criteria in our review. All included studies were
3.1. Study characteristics published in China.
In total, 9 of the 19 studies included in the review assessed
Our initial search identified 860 studies, which were then acupuncture versus haloperidol [24,25,27,29,30,32,38,39,41], two
reviewed for suitability for inclusion in this review. After removing studies [33,34] evaluated acupuncture versus risperidone, two
duplicates, 681 studies remained and were evaluated carefully for evaluated acupuncture versus tiapride [28,42], five evaluated
their eligibility for this review. Of the 681 potential abstracts/ electro-acupuncture versus haloperidol [26,31,35–37] and one
citations, 129 were retained for detailed review (Fig. 1). Consider- study reported on pharmacopuncture versus haloperidol [40]. The
ing the abstracts, 129 papers met the search inclusion criteria number of acupuncture sessions per patient ranged from 10 to 60
detailed above. The majority of the papers using acupuncture did sessions. The length of each treatment time ranged from 3 weeks to
not specifically focus on TS (n = 88) and were therefore excluded; 3 months. The most frequently used acupoints were GB20 and
others were excluded because they reported case studies (n = 3), or GV20. Most of the trials were one arm-randomized studies. Two
presented reviews (n = 10). Only RCTs examining the effectiveness trials [24,38] used a three-arm design. The number of patient
Table 1
Characteristics and the risk of bias assessment of included studies of acupuncture for Tourette syndrome.
Study Subjects (age range or mean age): Intervention type, Treatment sessions (treatment Control group Outcome Assessment
Duration of Tourette syndrome frequency); Treated acupoints measures risk of biasa
[24] 96 children(4–15y) and 9 subject (16– Acupuncture, 40 sessions (once everyday); MS1, MS5, a) Scalp acupuncture and herb Response U-U-U-U-L-
26y): 99 cases for 1–5y, 6 cases for 5–16y MS8 medicines: 40 days rate U-L
b) Haloperidol 0.5mg–8 mg/d
during 40 days
[25] 60 children (5–12 y): for 0.5-5y Acupuncture 40 sessions (once everyday); EX-HN3, Haloperidol Response U-U-U-U-L-
SP6,LR3, LI3, GB20, BL62, KI6 0.1 mg/d per body weight(kg) rate U-L
during 2 months
[26] 102 subjects (not reporting):for 1–8y Electro-acupuncture: 30 sessions (once everyday); Haloperidol 1.5mg–8 mg/d Response U-U-U-U-L-
PC6, LI4, GB20, GV20, Chorea-tremble control area rate U-L
[27] 49 children and adolescents (4–17y):for Acupuncture 20 sessions (once everyday); PC6, GB20, Haloperidol 1.5mg–6 mg/d Response U-U-U-U-L-
0.5-11y GV24, LR3, EX-HN1 rate U-L
[28] 140 children (4–15y):for 1–9y Acupuncture once in 2 days for 2 months: Motor area, Tiapride 100mg–500 mg/d for YGTSSb U-U-U-U-L-
Chorea-tremble control area 2 months L-L
[29] 102 children (3–15y):for 1–9y Acupuncture 60 sessions (once everyday): LI4, LR3, Haloperidol 0.5 mg/d for Response U-U-U-U-L-
GV20, HT7, BL10, SI4 60 days rate, U-L
[30] 45 children and adolescents (5–16y):for Acupuncture 10 sessions (once everyday): LI4, LR3, Haloperidol 1.5mg–8 mg/d for Response L-U-U-U-L-
1–5y GB20, GV24, EX-HN1 10 days rate U-L
[31] 60 children (6–12 y):for 0.5-6y Electro-acupuncture 36 sessions (once everyday): Haloperidol 1.5mg–8 mg/d for Response U-U-U-U-L-
MS1, MS5, MS8 36 days rate U-L
[32] 58 children and adolescents (4–16y):for Acupuncture 30 sessions (once everyday): LI4, LR3, Haloperidol 4mg–8 mg/d for Response U-U-U-U-L-
1.5–12y GB20 30 days rate U-L
[33] 60 children and adolescents (6–18y):for 1– Acupuncture 3 sessions per week for 3 months: MS1, Risperidone Response U-U-U-U-L-
7y MS5, MS8 0.5mg–1 mg/d for 3 months rate, L-L
YGTSS
[34] 60 children and adolescents (5–16y):for Acupuncture 3 sessions per week for 3 months: GV24, Risperidone Response U-U-U-U-L-
1–8y GB13 0.5mg–1 mg/d for 3 months rate, L-L
YGTSS
[35] 60 children (10.2y): for 2.15y Electro-acupuncture everyday for 6 weeks: GV20, Haloperidol 1mg–4 mg/d for 6 Response L-U-U-U-L-
GV24, BL23, GV14 weeks rate, L-L
YGTSS
[36] 60 subjects (not reporting):for 1–5y Electro-acupuncture 20 sessions(once everyday): Haloperidol 1.5mg–8 mg/d for Response U-U-U-U-L-
GV20, GB20,LI4, Chorea-tremble control area 20 days rate U-L
[37] 60 children (8.6y):for 1–8y Electro-acupuncture 60 sessions(once everyday): Haloperidol 2mg–8 mg/d for 2 Response U-U-U-U-L-
GV20, GB20,LI4,GV24, LR3, Chorea-tremble control months rate, L-L
area YGTSS
[38] 150 children (8.5y):for 1–10y Acupuncture 45 sessions for 3 months: GV20, LI4, Medication group: Response U-U-U-U-L-
GB20, GV16, LR3, KI3 Haloperidol 1.5mg–4 mg/d for rate, U-L
3 months
Herbal group: Yi-gan-san for
3 months
[39] 62 children and adolescents (11.29y):for Acupuncture 5 sessions per week for 2 months; GV20, Haloperidol 2mg–6 mg/d for 2 Response U-U-U-U-L-
1–7y GV24, TE23, LI4, PC6 months rate U-L
[40] 90 children (6.7y): for not reporting Acupuncture and pharmacopuncture 6 sessions per Haloperidol 1mg–2 mg/d for 3 Response U-U-U-U-L-
week for 3 weeks: GV20, EX-HN3 weeks rate U-L
[41] 28 children (5–14 y): for 1–3y Acupuncture 36 sessions for 45 days: HT7, LI4, LR3, Haloperidol 1mg–8 mg/d for Response L-U-U-U-L-
LR2, ST41, BL62, KI6 45 days rate U-L
[42] 87 children (2–15 y): for 0.5-3.2y Acupuncture 60 sessions for 3 months: LI4, GB20, Tiapride 150mg–450 mg/d for Response L-U-U-U-L-
GV20, EX-HN5, EX-HN1 3 months rate U-L
a
Assessment risk of bias: Random sequence generation, Allocation concealment, Blinding of participants, Incomplete outcome data, Selective reporting, Other bias: Low
risk of bias, categorised as ‘L', High risk of bias as “H”, Unclear risk of bias as “U”.
b
YGTT = Yale Global Tic Severity Scale.
Please cite this article in press as: S.-Y. Chung, et al., Acupuncture for Tourette syndrome: A systematic review and meta-analysis, Eur. J. Integr.
Med. (2016), http://dx.doi.org/10.1016/j.eujim.2016.09.001
G Model
EUJIM 598 No. of Pages 8
S.-Y. Chung et al. / European Journal of Integrative Medicine xxx (2016) xxx–xxx 5
sessions per patient ranged from 28 to 150 with a mean of 78.1 none of the authors mentioned if they used intention-to-treat
subjects per study. The diagnosis of TS was usually defined by analysis. Five studies [28,33–35,37] used the examiner’s YGTSS
clinical criteria (CCMD-2-R or 3). A total of 1483 patients ratings; however, others did not report global tic severity scores.
participated in the included studies, with ages ranging from 4 to There did not seem to be any other noticeable biases (e.g., baseline
26 years. Two of these trials [24,26] included adults while the imbalance, design-specific risk of bias and differential diagnostic
majority focused on the effect of acupuncture in children activity).
(aged < 18 years). In general, most studies assessed the improve-
ment rate of symptoms. The YGTSS was used to assess the degree of 3.3. Synthesis of results
tic severity in five [28,33–35,37] of the included studies. Table 1
lists the 19 RCTs that met the inclusion criteria, which formed the As seen in Fig. 2, a random-effects analysis showed a significant
total sample of 1483 participants. treatment effect for acupuncture compared to all control
medications (RR = 1.17, 95% CI: 1.10–1.25, p < 0.0001). Visual check
3.2. Risk of bias in included studies of the forest plot, Q statistic, and I2 statistic did not identify the
presence of heterogeneity among the studies (Chi2 = 28.39, p = 0.16,
Four [30,35,41,42] of the studies described their methods of I 2 = 25%).
randomization (Table 1). None of the studies described allocation There was a high RR in favor of group receiving acupuncture
concealment. All trials were conducted as open trials without experiencing a treatment response compared to the haloperidol
blinding of participants and outcome assessments. All trials medication group (RR = 1.22, 95% CI: 1.09–1.37, z = 3.41, p = 0.0006).
reported outcome measure data for all participants; however,
Please cite this article in press as: S.-Y. Chung, et al., Acupuncture for Tourette syndrome: A systematic review and meta-analysis, Eur. J. Integr.
Med. (2016), http://dx.doi.org/10.1016/j.eujim.2016.09.001
G Model
EUJIM 598 No. of Pages 8
6 S.-Y. Chung et al. / European Journal of Integrative Medicine xxx (2016) xxx–xxx
Two studies [33,34] compared acupuncture treatment with and even modification of external factors. No serious adverse
risperidone medication, and one study [42] compared acupuncture events were described in the trials included in this review.
with tiapride. In the two studies that used risperidone as the Fifteen studies compared acupuncture or electro-acupuncture
comparison condition, the summary effect was calculated as a with haloperidol medication. Each of these RCTs discovered that
significant treatment effect (RR = 1.31, 95% CI: 1.02, 1.67, z = 2.16, acupuncture was more effective at decreasing tic symptoms,
p = 0.03), with less heterogeneity observed (I 2 = 0%). The study yielding RRs of 1.19,1.14. In addition, two studies by Xu [33,34]
using tiapride as the comparison condition described no significant showed an RR in tic severity of 1.31 in the acupuncture group
difference (RR = 1.09, 95% CI: 0.92–1.28). Five studies [26,31,35–37] compared with risperidone. However, pharmacopuncture did not
compared electro-acupuncture treatment with haloperidol medi- appear to produce a significant difference versus haloperidol, in
cation. Merging these studies for assessment of improvement in tic contrast to the other 15 studies reviewed in the existing article.
severity using a random-effects model presented an RR of Evidence for the effectiveness of pharmacopuncture treatments is
improving symptoms in favor of electro-acupuncture treatment generally limited to small-sample studies. A greater percentage of
(RR = 1.14, 95% CI: 1.01, 1.28, z = 2.17, p = 0.03). Li [40] reported no patients from the acupuncture group were found to be optimistic
significance in the treatment group using pharmacopuncture responders compared with the medication group, causing in a
versus haloperidol (RR = 1.13, 95% CI: 0.98, 1.30). There was no possible bias in follow-up evaluation of tic symptoms. The main
observable asymmetry in the funnel plots of these 19 RCTs (Fig. 3). selected acupoints in the included studies were GB20, GV20, GV24,
Mao [28] and Xu [34] exhibited that the decrease of YGTSS was MS1, MS5, MS8 and were located on the head. However, the
significantly better in an acupuncture group than in a medication included studies were very heterogeneous in terms of chosen
group (MD = 8.38, 95% CI = 2.63–14.13; MD = 4.31, 95% CI: 2.80– acupoints and meridians. Additionally, the authors rated clinical
5.82). Meanwhile Xu[33] described no significant difference improvement rather than using the YGTSS. Although the summary
between the groups (MD = 0.31, 95% CI = 1.87–1.25). Combining of RRs of for the improvement rate of the included acupuncture
these results did not demonstrate a significant difference between trials showed favouring acupuncture, combining results in studies
groups using a random-effects analysis model (pooled MD = 3.46, using with YGTSS did not demonstrate a significant difference.
95% CI = 0.67, 7.62, z = 1.63, p = 0.10, I2 = 91%). Thus, there were limitations on the exactness and generalizability
Only one study observed and reported on adverse events. Liu of the results.
[38] reported that there were no adverse events in their Further problems with the observed studies relates to the
acupuncture treatment group. blinding process. The studies of acupuncture were not assessor-
blinded. In the study using YGTSS, the assessors who rated the
4. Discussion YGTSS were not blinded to the both groups of the patients. The
greatest inadequacy in the included studies was the disappoint-
The purpose of this systematic review was to present evidence- ment in describing the randomization process or the method of
based information on the effectiveness of acupuncture for TS by allocation concealment. Methodological heterogeneity inhibits
summarising the results of RCTs. The summary of RRs showed a drawing firm conclusions.
significant improvement of acupuncture groups (RR = 1.16, Fig. 2). Although antipsychotic treatments may have greater effective-
Our main result was that acupuncture meaningfully reduced tic ness than acupuncture for TS, this advantage appears to be
symptoms in patients with TS. While TS is usually managed with counterbalanced by the presence of significantly greater side
pharmacotherapy, this statistical analysis suggests that acupunc- effects, particularly extrapyramidal symptoms. In addition to side
ture could be an another treatment option with treatment effects effects, drugs carry the potential disadvantages of side effects, non-
comparable to those of psychotropic medications. Approaches compliance and unresponsiveness. It is worthwhile considering
used were diverse, including in terms of techniques and the use of acupuncture treatments in patients with TS, instead of or
acupuncture type, changing patients’ outlook on their condition, as well as pharmacotherapy, as have several advantages.
Please cite this article in press as: S.-Y. Chung, et al., Acupuncture for Tourette syndrome: A systematic review and meta-analysis, Eur. J. Integr.
Med. (2016), http://dx.doi.org/10.1016/j.eujim.2016.09.001
G Model
EUJIM 598 No. of Pages 8
S.-Y. Chung et al. / European Journal of Integrative Medicine xxx (2016) xxx–xxx 7
Please cite this article in press as: S.-Y. Chung, et al., Acupuncture for Tourette syndrome: A systematic review and meta-analysis, Eur. J. Integr.
Med. (2016), http://dx.doi.org/10.1016/j.eujim.2016.09.001
G Model
EUJIM 598 No. of Pages 8
8 S.-Y. Chung et al. / European Journal of Integrative Medicine xxx (2016) xxx–xxx
[31] Q.-y. Ge, H. Yang, Treatment of child tourette’s syndrome by scalp acupuncture, [37] L. Liu, X-l. Li, F. Wang, Y-f. Xu, X. Guan, Clinical effects and influences of
J. Sichuan Tradit. Chin. Med. (2008) 114–115. neurotransmitters on the treatment of GTS by using electroacupuncture on the
[32] Z.-r. Zhang, Clinical efficacy of acupuncture with plum needle acupuncture in head, Acta Chin. Med. Pharmacol. (2010) 128–131.
treating Tourette’s syndrome, Chin. J. Gen. Pract. (2009) 1331–1332. [38] H.-m. Liu, X.-d. Han, S. Dai, J. Lu, Comparation of therapeutic effects of YGS and
[33] S.-f. Xu, B.-c. Zhu, Observations on the curative effect on 30 cases of Dong-liu acupuncture on child tourette’s syndrome, Chin. Gen. Pract. 240 (2010) 1–2.
acupuncture on Tourette’s syndrome guiding, J. Tradit. Chin. Med. Pharm. [39] Y.-a. Jin, Treatment of Tourette's syndrome with the ‘Head-hand-foot triple
(2009) 58–59. acupuncture kinesitherapy Liaoning, J. Tradit. Chin. Med. 37 (2007) 272–273.
[34] S.-f. Xu, Treatment of 30 Cases of Gilles de la Tourette’s Syndrome by Jin three [40] Q. Li, Observation on therapeutic effect of 45 casse of tic disorders treated with
needle therapy, Shansi J. Tradit. Chin. Med. 12 (2009) 1648–1649. pharmacoacupuncture, Seek Med. Ask Med. (2012) 818.
[35] J. Mu, J. Cheng, J. Ao, L. Zho, J. Wang, W. Fang, Clinical study on 60 cases of gilles [41] Y. Sun, X.-l. Nie, Treatment of Tourrete's syndrome with Bai-hui and distal end
de la Tourette's syndrome by electroacupuncture and psychotherapy jiangsu, J. of four limbs acupuncture, J. Clin. Acupuncture Moxibustion 30 (2014) 29–30.
Tradit. Chin. Med. 41 (2009) 49–51. [42] X-j. Zhang, X.-l. Wang, Y. Wei, Y.-z. Wu, Clinical study of treatment of Tourette's
[36] L. Lui, X.-p. Yu, Y.-l. Li, Y.-f. Xu, B. Qu, Clinical observation of effects on the sydrome by Dongliu acupuncture Shandong, J. Tradit. Chin. Med. 34 (2015)
Treatment of GTS by Using Electroacupuncture on the Head, J. Clin. 266–267.
Acupuncture Moxibustion 26 (2010) 21–22.
Please cite this article in press as: S.-Y. Chung, et al., Acupuncture for Tourette syndrome: A systematic review and meta-analysis, Eur. J. Integr.
Med. (2016), http://dx.doi.org/10.1016/j.eujim.2016.09.001